Literature DB >> 28911956

ALK and ROS1 Double-Rearranged Lung Squamous Cell Carcinoma Responding to Crizotinib Treatment: A Case Report.

Qiong Li1, Jian Wu2, Li-Xu Yan3, Jun-Wei Huang4, Zhou Zhang5, Jin-E Zhang6, Xing-Lin Gao4, Ze-Ru Luo4, Jing Liu5, Shi-Fang Yang4, Yan-Hui Liu3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28911956     DOI: 10.1016/j.jtho.2017.08.021

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  5 in total

Review 1.  Characteristics and Response to Crizotinib in ALK-Rearranged, Advanced Non-Adenocarcinoma, Non-Small Cell Lung Cancer (NA-NSCLC) Patients: a Retrospective Study and Literature Review.

Authors:  Bo Zhang; Yanwei Zhang; Jianlin Xu; Xueyan Zhang; Tianqing Chu; Shuyuan Wang; Jie Qian; Rong Qiao; Jun Lu; Lele Zhang; Baohui Han
Journal:  Target Oncol       Date:  2018-10       Impact factor: 4.493

Review 2.  Lung cancer in never smokers-the East Asian experience.

Authors:  Fei Zhou; Caicun Zhou
Journal:  Transl Lung Cancer Res       Date:  2018-08

3.  ALK-rearranged squamous cell carcinoma of the lung.

Authors:  Qiyi Meng; Yujie Dong; Hong Tao; Liang Shi; Li Tong; Junfang Tang; Shucai Zhang; Zhe Liu
Journal:  Thorac Cancer       Date:  2021-02-09       Impact factor: 3.500

4.  Coexpression of ΔNp63/p40 and TTF1 Within Most of the Same Individual Cells Identifies Life-Threatening NSCLC Featuring Squamous and Glandular Biphenotypic Differentiation: Clinicopathologic Correlations.

Authors:  Giuseppe Pelosi; Matteo Bulloni; Martina Vescio; Silvia Uccella; Fabien Forest; Giorgia Leone; Massimo Barberis; Daoud Rahal; Paola Bossi; Giovanna Finzi; Deborah Marchiori; Marco De Luca; Fausto Sessa; Sergio Harari; Manuela Spinelli; Patrizia Viola; Paolo Macrì; Stefania Maria; Antonio Rizzo; Antonio Picone; Linda Pattini
Journal:  JTO Clin Res Rep       Date:  2021-09-02

5.  Brigatinib treated ALK positive lung squamous cell carcinoma after failed chemotherapy: A case report.

Authors:  Shuluan Li; Pei Zhang; Tianyu Wang; Jie Wang; Jianchun Duan
Journal:  Thorac Cancer       Date:  2021-10-13       Impact factor: 3.500

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.